| Literature DB >> 19932381 |
Barney J Stern1, Allen Aksamit, David Clifford, Thomas F Scott.
Abstract
Neurosarcoidosis is a diagnostic consideration in diverse clinical settings. Efforts should be made to secure pathologic confirmation of systemic sarcoidosis; only rarely is central nervous system (CNS) pathologic confirmation available. CNS infection and malignancy should be reasonably excluded before making a diagnosis of CNS sarcoidosis. Corticosteroid therapy alone may not be sufficient to treat neurosarcoidosis; adjunct immunosuppressive agents are increasingly used to achieve an optimal clinical outcome.Entities:
Mesh:
Year: 2010 PMID: 19932381 DOI: 10.1016/j.ncl.2009.09.012
Source DB: PubMed Journal: Neurol Clin ISSN: 0733-8619 Impact factor: 3.806